coronavirus. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: patients in this group, in addition to drug treatment according to the national guidelines for the new coronavirus, They receive saffron supplements for 14 days. (4
Sponsors
The University of Mohaghegh Ardabili
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Outpatients with covid 19
Exclusion criteria
Exclusion criteria: History of allergy to saffron and its derivatives People with liver, kidney and respiratory disorders Lactating and pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough. Timepoint: Before and 14 days after the start of treatment. Method of measurement: Physical examination.;Breathing rate. Timepoint: Before and 14 days after the start of treatment. Method of measurement: Physical examination.;Body temperature. Timepoint: Before and 14 days after the start of treatment. Method of measurement: Physical examination.;Speed of improvement. Timepoint: Before and 14 days after the start of treatment. Method of measurement: Physical examination.;Inflammatory biomarkers. Timepoint: Before and 14 days after the start of treatment. Method of measurement: blood test.;The amount of C-reactive protein. Timepoint: Before and 14 days after the start of treatment. Method of measurement: blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum level of specific IgG antibody for N and S antigens. Timepoint: One month after training. Method of measurement: Eliza method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFateme Halalkhor
University of Tabriz
Outcome results
None listed